MYC UNDEREXPRESSION Detail (hg19) (MYC)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr8:128,747,680-128,755,197 |
hg38 | chr8:127,735,434-127,742,951 |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Type | Database | ID | Link |
---|---|---|---|
Gene | MIM | ||
HGNC | |||
Ensembl | |||
NCBI | |||
Gene Cards | |||
OncoKB |
Type | Database | ID | Link |
---|---|---|---|
Variant | TogoVar | ||
COSMIC | |||
MONDO |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
[No Data.]
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In vivo experiments revealed that liposomal formulations of c-Myc antisense and DXR, both delivered ... | MMMP | Detail |
Increase of cisplatin sensitivity by c-Myc antisense oligodeoxynucleotides in a human metastatic mel... | MMMP | Detail |
MYC downregulation sensitizes melanoma to radiation by inhibiting MLH1 and MSH2 expression. Sensitiz... | MMMP | Detail |
Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-My... | MMMP | Detail |
Specific c-Myc inhibition increased melanoma susceptibility to antineoplastic drugs with different m... | MMMP | Detail |
Specific c-Myc inhibition increased melanoma susceptibility to antineoplastic drugs with different m... | MMMP | Detail |
Specific c-Myc inhibition increased melanoma susceptibility to antineoplastic drugs with different m... | MMMP | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg19
- Position
- chr8:128,747,680-128,755,197
- Variant Type
- cnv
Genome browser